The Clinical Characteristics and Prognosis of Patients With Anthracycline-Induced Cardiomyopathy

被引:0
作者
Thomas, Garry R.
Siu, Vince
McDonald, Michael A.
Ross, Heather J.
Delgado, Diego H.
Billia, Filio
Rao, Vivek
Amir, Eitan
Thavendiranathan, Paaladinesh
机构
关键词
Cardiomyopathy; Ventricular function; Heart failure; adult; Cardiooncology;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
18687
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Anthracycline-induced cardiomyopathy in childhood. Pathogenesis, diagnostics and therapy
    Hauser, M.
    Kandolf, R.
    Hess, J.
    MONATSSCHRIFT KINDERHEILKUNDE, 2012, 160 (02) : 129 - 134
  • [22] Anthracycline-induced cardiac toxicity: A clinical review
    Abbas, Adil Abdelhameed
    AlAzmi, Aeshah Abdu Mubarak
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2019, 40 (04) : 465 - 475
  • [23] Atrial Remodeling in an Ovine Model of Anthracycline-Induced Nonischemic Cardiomyopathy: Remodeling of the Same Sort
    Lau, Dennis H.
    Psaltis, Peter J.
    Mackenzie, Lorraine
    Kelly, Darren J.
    Carbone, Angelo
    Worthington, Michael
    Nelson, Adam J.
    Zhang, Yuan
    Kuklik, Pawel
    Wong, Christopher X.
    Edwards, James
    Saint, David A.
    Worthley, Stephen G.
    Sanders, Prashanthan
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2011, 22 (02) : 175 - 182
  • [24] Anthracycline-induced cardiomyopathy, an essential diagnostic and therapeutic problem in oncological practice
    Breborowicz, Elzbieta
    Breborowicz, Piotr
    Litwiniuk, Maria
    Tomczak, Piotr
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2007, 11 (04): : 204 - 209
  • [25] Molecular pathogenetic mechanisms and new therapeutic perspectives in anthracycline-induced cardiomyopathy
    Distefano, Giuseppe
    ITALIAN JOURNAL OF PEDIATRICS, 2009, 35
  • [26] The use of sacubitril/valsartan in anthracycline-induced cardiomyopathy: A mini case series
    Sheppard, Christina E.
    Anwar, Maria
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (05) : 1231 - 1234
  • [27] 123I-MIBG imaging for detection of anthracycline-induced cardiomyopathy
    Laursen, Adam H.
    Thune, Jens Jakob
    Hutchings, Martin
    Hasbak, Philip
    Kjaer, Andreas
    Elming, Marie B.
    Ripa, Rasmus S.
    CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING, 2018, 38 (02) : 176 - 185
  • [28] Beta-Blockers for the Prevention of Anthracycline-Induced Cardiomyopathy: Systematic Review and Meta-Analysis
    Knijnik, Leonardo M.
    Rivera, Manuel
    Fernandes, Amanda D.
    Cardoso, Rhanderson M.
    Cohen, Mauricio
    CIRCULATION, 2018, 138
  • [29] CardioMEMS-Guided CAR T Cell Therapy for Lymphoma in a Patient With Anthracycline-Induced Cardiomyopathy
    Kanelidis, Anthony J.
    Raikhelkar, Jayant
    Kim, Gene
    Sayer, Gabriel
    Bishop, Michael R.
    Polonsky, Tamar S.
    Uriel, Nir
    JACC: CARDIOONCOLOGY, 2020, 2 (03): : 515 - 518
  • [30] Anthracycline-induced cardiotoxicity and senescence
    Booth, Laura K.
    Redgrave, Rachael E.
    Folaranmi, Omowumi
    Gill, Jason H.
    Richardson, Gavin D.
    FRONTIERS IN AGING, 2022, 3